Background: Regulation authorities have recently advised against the use of hormone replacement therapy (HRT) as a first choice treatment for postmenopausal osteoporosis, modifying the past consensus.
Aim: Analyse the sensibility to and prescription attitude for osteoporosis.
Setting: Survey.